(Sacramento, CA) Iantrek is scaling rapidly to meet growing demand for our groundbreaking glaucoma technologies, AlloFlo™ Uveo , a bio-interventional solution that unlocks a new frontier in glaucoma management, as well as C. Rex , the first and only technology to dilate Schlemm’s canal, stretch collector channel ostia, and precisely excise diseased trabecular meshwork in one smooth, continuous motion. With 2.5 million eyes in need of advanced solutions, we are expanding our commercial team to ensure every surgeon and patient has access to this transformative technology. About Iantrek Iantrek Inc., founded by Dr. Sean Ianchulev, is dedicated to meaningful innovation in glaucoma care. The company develops next-generation bio
Read Less
